Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical furosemide before endoscopic sinus surgery in chronic rhinosinusitis
IRCT20151123025202N3Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of furosemide in chronic rhinosinusitis (CRS) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Amount of bleeding during surgery and Quality of surgical field. Started Nov 2019; status: completed.
02
Drugs
furosemide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on IRCT20151123025202N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151123025202N3.